Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and β-arrestin-2 recruitment: A mechanism regulating stress and anxiety responses

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 293, Issue 1, 2007, Pages

  Oakley, Robert H ^a   Olivares Reyes, J Alberto ^b   Hudson, Christine C ^a   Flores Vega, Fabiola ^b   Dautzenberg, Frank M ^c   Hauger, Richard L ^d  

^a Xsira Pharmaceuticals   (United States)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Corticotropin releasing factor; G protein coupled receptor kinase; Internalization; Receptor phosphorylation; Stress adaptation

Indexed keywords

BETA ARRESTIN 1; BETA ARRESTIN 2; CLATHRIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR KINASE; ISOPROTEIN; SERINE; THREONINE;

ANXIETY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; CYTOSOL; EMBRYO; HUMAN; HUMAN CELL; INTERNALIZATION; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE; STRESS;

AMINO ACID SEQUENCE; ANXIETY; ARRESTINS; CELL LINE; CELLS, CULTURED; CYCLIC AMP; EPITOPES; HUMANS; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; PROTEIN TRANSPORT; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, G-PROTEIN-COUPLED; STRESS, PSYCHOLOGICAL; TRANSFECTION;

EID: 34447622268     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00099.2006     Document Type: Article

References (55)

1. Barak LS, Tiberi M, Freedman NJ, Kwatra MM, Lefkowitz RJ, Caron MG. A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist mediated beta2-adrenergic receptor sequestration. J Biol Chem 269: 2790-2795, 1994.
2. Barak LS, Warabi K, Feng X, Caron MG, Kwatra MM. Real-time visualization of the cellular redistribution of G protein-coupled receptor kinase 2 and beta-arrestin 2 during homologous desensitization of the substance P receptor. J Biol Chem 274: 7565-7569, 1999.
3. 2- adrenergic receptor delays onset of agonist-promoted desensitization. Nature (Lond) 333: 370-373, 1988.
4. Braun L, Christophe T, Boulay F. Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a β-arrestin, dynamin, and clathrin-dependent pathway. J Biol Chem 278: 4277-4285, 2003.
5. Dautzenberg FM, Hauger RL. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23: 71-77, 2002.
6. 1 receptors: a potential mechanism regulating stress adaptation. Am J Physiol Regul Integr Comp Physiol 280: R935-R946, 2001.
7. 1 receptor desensitization. Biochem Biophys Res Commun 298: 303-308, 2002.
8. Dautzenberg FM, Kilpatrick GJ, Wille S, Hauger RL. The ligandselective domains of corticotropin-releasing factor type 1 and type 2 receptors reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile. J Neurochem 73: 821-829, 1999.
9. DeGraff JL, Gurevich VV, Benovic JL. The third intracellular loop of α2-adrenergic receptors determines subtype specificity of arrestin interaction. J Biol Chem 277: 43247-42352, 2002.
10. Dieterich KD, Grigoriadis DE, DeSouza EB. Homologous desensitization of human corticotropin-releasing factor1 receptor in stable transfected mouse fibroblast cells. Brain Res 710: 287-292, 1996.
11. Drake MT, Shenoy SK, Lefkowitz RJ. Trafficking of G protein-coupled receptors. Circ Res 99: 570-582, 2006.
12. Ferguson SS. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53: 1-24, 2001.
13. Fredericks ZL, Pitcher JA, Lefkowitz RJ. Identification of the G protein-coupled receptor kinase phosphorylation sites in the human β2-adrenergic receptor. J Biol Chem 271: 13796-13803, 1996.
14. Goodman OB Jr, Krupnick JG, Santini F, Gurevich VV, Penn RB, Gagnon AW, Keen JH, Benovic JL. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 383: 447-450, 1996.
15. Grigoriadis DE. The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders. Expert Opin Ther Targets 9: 651-684, 2005.
16. Hauger RL, Risbrough V, Brauns O, Dautzenberg FM. CRF receptor signaling in the central nervous system: new molecular targets for affective disorders. CNS Neurol Disord Drug Targets 5: 453-479, 2006.
17. Hauger RL, Olivares-Reyes JA, Braun S, Catt KJ, Dautzenberg FM. Regulation of corticotropin releasing factor type 1 receptor phosphorylation and desensitization by protein kinase C: a possible role in stress adaptation. J Pharmacol Exp Therap 306: 794-803, 2003.
18. Hauger RL, Dautzenberg FM, Flaccus A, Liepold T, Spiess J. Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: rapid and reversible homologous desensitization but prolonged recovery. J Neurochem 68: 2308-2316, 1997.
19. Hauger RL, Smith RD, Braun S, Dautzenberg FM, Catt KJ. Rapid agonist-induced phosphorylation of the human CRF receptor, type 1: a potential mechanism for homologous desensitization. Biochem Biophys Res Commun 268: 572-576, 2000.
20. Hoffman AR, Ceda G, Reisine TD. Corticotropin-releasing factor desensitization of adrenocorticotropic hormone release is augmented by arginine vasopressin. J Neurosci 5: 234-242, 1985.
21. 1 receptor desensitization and internalization. Mol Pharm 67: 655-664, 2005.
22. Holmes KD, Babwah AV, Dale LB, Poulter MO, Ferguson SS. Differential regulation of corticotropin releasing factor 1alpha receptor endocytosis and trafficking by beta-arrestins and Rab GTPases. J Neurochem 96: 934-949, 2006.
23. 2C2 adrenergic receptor is required for agonist-promoted phosphorylation and desensitization. Biochemistry 34: 11946-11953, 1995.
24. Keck ME, Ohl F, Holsboer F, Muller MB. Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Neurosci Biobehav Rev 29: 867-889, 2005.
25. 1 dopamine receptor desensitization. J Biol Chem 279: 7999-8010, 2004.
26. Kohout TA, Lefkowitz RJ. Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. Mol Pharmacol 63: 9-18, 2003.
27. Krasel C, Vilargdaga JP, Bunemann M, Lohse MJ. Kinetics of G-protein-coupled receptor signaling and desensitization. Biochem Soc Trans 32: 1029-1031, 2004.
28. Laporte SA, Oakley RH, Zhang J, Holt JA, Ferguson SS, Caron MG, Barak LS. The beta2-adrenergic receptor/beta-arrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci USA 96: 3712-3717, 1999.
29. Laporte SA, Oakley RH, Holt JA, Barak LS, Caron MG. The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta2-adrenergic receptor into clathrin-coated pits. J Biol Chem 275: 23120-23126, 2000.
30. 2 muscarinic acetylcholine receptor is precluded by an inhibitory element in the third intracellular loop. J Biol Chem 275: 9284-9289, 2000.
31. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by β-arrestins. Science 308: 512-517, 2005.
32. Lohse MJ, Andexinger S, Pitcher J, Trukawinski S, Codina J, Faure JP, Caron MG, Lefkowitz RJ. Receptor-specific desensitization with purified proteins: kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta2-adrenergic receptor and rhodopsin. J Biol Chem 267: 8558-8564, 1992.
33. Marion S, Oakley RH, Kim KM, Caron MG, Barak LS. A beta-arrestin binding determinant common to the second-intracellular loops of Rhodopsin-family G protein-coupled receptors. J Biol Chem 281: 2932-2938, 2006.
34. Markovic D, Papadopoulou N, Teli T, Randeva H, Levine MA, Hillhouse EW, Grammatopoulos D. Differential responses of CRH receptor type 1 variants to PKC phosphorylation. J Pharmacol Exp Ther 319: 1032-1042, 2006.
35. 2-adrenergic receptor kinase and β-arrestin determine kinetics of internalization. Mol Pharm 51: 800-808, 1997.
36. Min L, Ascoli M. The association of arrestin-3 with the human lutropin/ choriogonadotropin receptors depends mostly on receptor activation rather than on receptor phosphorylation. J Biol Chem 277: 702-710, 2002.
37. Nemeroff CB, Vale WW. The neurobiology of depression: inroads to treatment and new drug discovery. J Clin Psychiatry 66, Suppl 7: 5-13, 2005.
38. Neuschafer-Rube F, Hermosilla R, Rehwald M, Ronnstrand L, Schulein R, Wernstedt C, Puschel GP. Identification of a Ser/Thr cluster in the C-terminal domain of the human prostaglandin receptor EP4 that is essential for agonist-induced beta-arrestin1 recruitment but differs from apparent principal phosphorylation site. Biochem J 379: 573-585, 2004.
39. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS. Differential affinities of visual arrestin, β-arrestin1, and β-arrestin2 with G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 275: 17201-17210, 2000.
40. Oakley RH, Barak LS, Caron MG. Real time imaging of GPCR-mediated arrestin translocation as a strategy to evaluate receptor-protein interactions. In: G Protein Coupled Receptor-Protein Interactions, edited by George SR and O'Dowd BF. Hoboken, NJ: Wiley, 2005, p. 53-80.
41. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG. Association of β-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J Biol Chem 274: 32248-32257, 1999.
42. Oakley RH, Hudson CC, Cruickshank RD, Meyers DM, Payne RE, Rehm SM, Loomis CR. The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G protein-coupled receptors. Assay Drug Develop Tech 1: 21-30, 2002.
43. Oakley RH, Cowan CL, Hudson CC, Loomis CR. Transfluor provides a universal cell-based assay for screening G protein coupled receptors. In: Handbook of Assay Development in Drug Discovery, edited by Minor L. Boca Raton, FL: CRC, 2006, p. 431-453.
44. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG. Molecular determinants underlying the formation of stable intracellular G protein-coupled-β-arrestin complexes after receptor endocytosis. J Biol Chem 276: 19452-19460, 2001.
45. Penn RB, Benovic JL. Mechanisms of receptor regulation. In: Handbook of Physiology. Endocrinology. Cellular Endocrinology, edited by Conn PM. Bethesda, MD: Am Physiol Sci, 1998, vol. I, sect. 7, chapt. 7, p. 145.
46. Perrin MH, Vale W. Corticotropin-releasing factor receptors. In: Understanding G Protein-coupled Receptors and Their Role in the CNS, edited by Pangalos MN and Davies CH. New York, NY: Oxford Univ Press, 2002.
47. Perry SJ, Junger S, Kohout TA, Hoare SRJ, Struthers RS, Grigoriadis DE, Maki RA. Distinct conformations of the corticotropin releasing factor type 1 receptor adopted following agonist and antagonist binding are differentially regulated. J Biol Chem 280: 11560-11568, 2005.
48. Rasmusson TN, Novak I, Nielsen SM. Internalization of the human CRF receptor 1 is independent of classical phosphorylation sites and of β-arrestin 1 recruitment. Eur J Biochem 271: 4366-4374, 2004.
49. Reisine T, Hoffman A. Desensitization of corticotropin releasing factor receptors. Biochem Biophys Res Commun 111: 919-925, 1983.
50. Reiter E, Lefkowitz RJ. GRKs and β-arrestins: roles in receptor silencing, trafficking, and signaling. Trends Endocrinol Metab 17: 159-165, 2006.
51. Roseboom PH, Urben CM, Kalin N. Persistent corticotropin-releasing factor1 receptor desensitization and downregulation in the human neuroblastoma cell line IMR-32. Brain Res Mol Brain Res 92: 115-127, 2001.
52. Scott MG, Le Rouzic E, Perianin A, Pierotti V, Enslen H, Benichou S, Marullo S, Benmerah A. Differential nucleocytoplasmic shuttling of beta-arrestins: characterization of a leucine-rich nuclear export signal in beta-arrestin2. J Biol Chem 277: 37693-37701, 2002.
53. Teli T, Markovic D, Levine MA, Hillhouse EW, Grammatopoulos DK. Regulation of corticotropin-releasing hormone (CRH) receptor type 1α signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization. Mol Endocrinol 19: 474-490, 2005.
54. Vilardaga JP, Krasel C, Chauvin S, Bambino T, Lohse MJ, Nissenson RA. Internalization determinants of the parathyroid hormone receptor differentially regulate β-arrestin/receptor association. J Biol Chem 277: 8121-8129, 2002.
55. von Zastrow M. Mechanisms regulating membrane trafficking of G protein-coupled receptors in the endocytic pathway. Life Sci 74: 217-224, 2003.